BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 27494730)

  • 1. Atrial natriuretic peptide therapy and in-hospital mortality in acute myocardial infarction patients undergoing percutaneous coronary intervention.
    Isogai T; Matsui H; Tanaka H; Fushimi K; Yasunaga H
    Int J Cardiol; 2016 Nov; 222():163-170. PubMed ID: 27494730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rationale and design of a large-scale trial using atrial natriuretic peptide (ANP) as an adjunct to percutaneous coronary intervention for ST-segment elevation acute myocardial infarction: Japan-Working groups of acute myocardial infarction for the reduction of Necrotic Damage by ANP (J-WIND-ANP).
    Asakura M; Jiyoong K; Minamino T; Shintani Y; Asanuma H; Kitakaze M;
    Circ J; 2004 Feb; 68(2):95-100. PubMed ID: 14745141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of oral beta-blocker therapy on mortality after primary percutaneous coronary intervention for Killip class 1 myocardial infarction.
    Hioki H; Motoki H; Izawa A; Kashima Y; Miura T; Ebisawa S; Tomita T; Miyashita Y; Koyama J; Ikeda U
    Heart Vessels; 2016 May; 31(5):687-93. PubMed ID: 25863805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of carperitide on in-hospital mortality of patients admitted for heart failure: propensity score analyses.
    Ogiso M; Isogai T; Okabe Y; Ito K; Tsuji M; Tanaka H
    Heart Vessels; 2017 Aug; 32(8):916-925. PubMed ID: 28220240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential time trends of outcomes and costs of care for acute myocardial infarction hospitalizations by ST elevation and type of intervention in the United States, 2001-2011.
    Sugiyama T; Hasegawa K; Kobayashi Y; Takahashi O; Fukui T; Tsugawa Y
    J Am Heart Assoc; 2015 Mar; 4(3):e001445. PubMed ID: 25801759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Outcomes of Patients With Sepsis With Versus Without Acute Myocardial Infarction and Comparison of Invasive Versus Noninvasive Management of the Patients With Infarction.
    Smilowitz NR; Gupta N; Guo Y; Bangalore S
    Am J Cardiol; 2016 Apr; 117(7):1065-71. PubMed ID: 26853952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temporal Trends and Outcomes of Patients Undergoing Percutaneous Coronary Interventions for Cardiogenic Shock in the Setting of Acute Myocardial Infarction: A Report From the CathPCI Registry.
    Wayangankar SA; Bangalore S; McCoy LA; Jneid H; Latif F; Karrowni W; Charitakis K; Feldman DN; Dakik HA; Mauri L; Peterson ED; Messenger J; Roe M; Mukherjee D; Klein A
    JACC Cardiovasc Interv; 2016 Feb; 9(4):341-351. PubMed ID: 26803418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of arterial access site selection on outcomes in primary percutaneous coronary intervention: are the results of randomized trials achievable in clinical practice?
    Mamas MA; Ratib K; Routledge H; Neyses L; Fraser DG; de Belder M; Ludman PF; Nolan J;
    JACC Cardiovasc Interv; 2013 Jul; 6(7):698-706. PubMed ID: 23769648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gender disparity in the use of drug-eluting stents during percutaneous coronary intervention for acute myocardial infarction.
    Iyanoye A; Moreyra AE; Swerdel JN; Gandhi SK; Cabrera J; Cosgrove NM; Kostis JB;
    Catheter Cardiovasc Interv; 2015 Aug; 86(2):221-8. PubMed ID: 25645156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human atrial natriuretic peptide and nicorandil as adjuncts to reperfusion treatment for acute myocardial infarction (J-WIND): two randomised trials.
    Kitakaze M; Asakura M; Kim J; Shintani Y; Asanuma H; Hamasaki T; Seguchi O; Myoishi M; Minamino T; Ohara T; Nagai Y; Nanto S; Watanabe K; Fukuzawa S; Hirayama A; Nakamura N; Kimura K; Fujii K; Ishihara M; Saito Y; Tomoike H; Kitamura S;
    Lancet; 2007 Oct; 370(9597):1483-93. PubMed ID: 17964349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of weekend admission for acute myocardial infarction on in-hospital mortality: a retrospective cohort study.
    Isogai T; Yasunaga H; Matsui H; Tanaka H; Ueda T; Horiguchi H; Fushimi K
    Int J Cardiol; 2015 Jan; 179():315-20. PubMed ID: 25464474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of Post-TKA Acute Myocardial Infarction in Patients With a History of Myocardial Infarction or Coronary Stent.
    Kumar A; Tsai WC; Tan TS; Chiu LT; Kung PT; Lo CK; Ku MC
    Clin Orthop Relat Res; 2016 Feb; 474(2):479-86. PubMed ID: 26566978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatments and in-hospital mortality in acute myocardial infarction patients with rheumatoid arthritis: a nationwide retrospective cohort study in Japan.
    Isogai T; Matsui H; Tanaka H; Yokogawa N; Fushimi K; Yasunaga H
    Clin Rheumatol; 2017 May; 36(5):995-1004. PubMed ID: 28124758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of prasugrel and clopidogrel-treated patients with acute coronary syndrome undergoing percutaneous coronary intervention: A propensity score-matched analysis of the Acute Myocardial Infarction in Switzerland (AMIS)-Plus Registry.
    Kurz DJ; Radovanovic D; Seifert B; Bernheim AM; Roffi M; Pedrazzini G; Windecker S; Erne P; Eberli FR
    Eur Heart J Acute Cardiovasc Care; 2016 Feb; 5(1):13-22. PubMed ID: 25614494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of atrial natriuretic peptide on left ventricular remodelling in patients with acute myocardial infarction.
    Kasama S; Furuya M; Toyama T; Ichikawa S; Kurabayashi M
    Eur Heart J; 2008 Jun; 29(12):1485-94. PubMed ID: 18490430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-terminal pro-atrial natriuretic peptide (N-ANP) and N-terminal pro-B-type natriuretic peptide (N-BNP) in the prediction of death and heart failure in unselected patients following acute myocardial infarction.
    Squire IB; O'Brien RJ; Demme B; Davies JE; Ng LL
    Clin Sci (Lond); 2004 Sep; 107(3):309-16. PubMed ID: 15182235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Underuse of coronary intervention and its impact on mortality in the elderly with myocardial infarction. A propensity-matched analysis from the Hungarian Myocardial Infarction Registry.
    Komócsi A; Simon M; Merkely B; Szűk T; Kiss RG; Aradi D; Ruzsa Z; Andrássy P; Nagy L; Lupkovics G; Kőszegi Z; Ofner P; Jánosi A
    Int J Cardiol; 2016 Jul; 214():485-90. PubMed ID: 27100339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B-type natriuretic peptide and risk of contrast-induced acute kidney injury in acute ST-segment-elevation myocardial infarction: a substudy from the HORIZONS-AMI trial.
    Jarai R; Dangas G; Huber K; Xu K; Brodie BR; Witzenbichler B; Metzger DC; Radke PW; Yu J; Claessen BE; Genereux P; Mehran R; Stone GW
    Circ Cardiovasc Interv; 2012 Dec; 5(6):813-20. PubMed ID: 23192919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In-hospital Takotsubo syndrome versus in-hospital acute myocardial infarction among patients admitted for non-cardiac diseases: a nationwide inpatient database study.
    Isogai T; Matsui H; Tanaka H; Fushimi K; Yasunaga H
    Heart Vessels; 2019 Sep; 34(9):1479-1490. PubMed ID: 30903314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between time to percutaneous coronary intervention and hospital mortality in non-STEMI: a prospective multicenter observational study.
    Kim TG; Shin SD; Song KJ; Lee YJ; Lee EJ; Ro YS; Ahn KO
    Am J Emerg Med; 2015 Nov; 33(11):1591-6. PubMed ID: 26186994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.